查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722653

2025-2033年癌症恶病质市场（依治疗、作用方式、配销通路及地区）报告

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球癌症恶病质市场规模达 22 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 30 亿美元，2025-2033 年期间的成长率 (CAGR) 为 3.9%。推动市场发展的因素包括全球癌症发病率的上升、对恶病质对患者预后重大影响的认识的不断加深以及针对性治疗研究的不断增加，所有这些都旨在提高患者的生活品质和治疗效果。

癌症恶病质是指一种多因素、宿主吞噬细胞消耗综合征，其特征是系统性发炎、非自愿性瘦体重损失、蛋白质负平衡、食慾不振和肌肉萎缩。它是由于各种慢性疾病的发生引起的，包括结核病（TB）、多发性硬化症、慢性阻塞性肺病（COPD）和人类免疫缺陷病毒（HIV）。癌症恶病质可以利用各种疗法来治疗，例如黄体素、皮质类固醇和联合疗法。其中，黄体素是一种合成或天然的类固醇激素，可以改善食慾并促进体重增加，而皮质类固醇有助于减轻发炎和抑制过度活跃的免疫系统。

癌症恶病质市场趋势：

癌症和恶病质的盛行率不断上升，尤其是在老年人口不断增加的情况下，这促进了对先进治疗方法和药物的需求，反过来又主要推动了市场成长。消费者对治疗癌症恶病质的新型治疗药物的认识不断提高，进一步证实了这一点。此外，患者透过药物治疗、非药物治疗和临床试验逐渐倾向于采用联合疗法来改善瘦体重（LBM），这也是另一个促进生长的因素。同时，广泛使用多种食慾刺激剂（如醋酸甲地孕酮、地塞米松和甲基泼尼松龙）来改善消化，也促进了市场的成长。此外，强调开发治疗癌症恶病质的有效药物的重大技术进步正在进一步推动市场成长。除此之外，各国政府机构和非政府组织（NGO）正在采取许多有利倡议，让人们了解癌症恶病质的原因、症状以及使用先进治疗方法的好处，这为市场创造了积极的前景。

本报告回答的关键问题

  • 2024 年全球癌症恶病质市场规模？ 2025 年至 2033 年期间全球癌症恶病质市场的预期成长率为何？
  • 推动全球癌症恶病质市场的关键因素有哪些？
  • COVID-19 对全球癌症恶病质市场有何影响？
  • 根据治疗方法，全球癌症恶病质市场如何分布？
  • 根据作用方式，全球癌症恶病质市场如何分布？
  • 全球癌症恶病质市场的主要地区有哪些？
  • 全球癌症恶病质市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球癌症恶病质市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：按治疗学

  • 黄体素
  • 皮质类固醇
  • 合併治疗
  • 其他的

第七章：市场区隔：依行动模式

  • 食慾刺激剂
  • 减肥稳定剂

第八章：市场区隔：按配销通路

  • 医院商店
  • 零售药局
  • 网路药局

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AAVogen Inc.
    • Actimed Therapeutics Ltd.
    • Aphios Corporation
    • Artelo Biosciences Inc.
    • AVEO Pharmaceuticals Inc.
    • Fresenius Kabi AG (Fresenius SE & Co. KGaA)
    • Helsinn Healthcare SA
    • Merck & Co. Inc.
    • NGM Biopharmaceuticals Inc.
    • Pfizer Inc.
    • Tetra Bio-Pharma
Product Code: SR112025A5338

The global cancer cachexia market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The market is driven by the rising global cancer incidence, the growing recognition of cachexia's significant impact on patient outcomes, and increased research into targeted therapies, all of which aim to enhance patient quality of life and treatment effectiveness.

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Therapeutics:

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others

Breakup by Mode of Action:

  • Appetite Stimulators
  • Weight Loss Stabilizers

Breakup by Distribution Channel:

  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Key Questions Answered in This Report

  • 1.What was the size of the global cancer cachexia market in 2024?
  • 2.What is the expected growth rate of the global cancer cachexia market during 2025-2033?
  • 3.What are the key factors driving the global cancer cachexia market?
  • 4.What has been the impact of COVID-19 on the global cancer cachexia market?
  • 5.What is the breakup of the global cancer cachexia market based on the therapeutics?
  • 6.What is the breakup of the global cancer cachexia market based on the mode of action?
  • 7.What are the key regions in the global cancer cachexia market?
  • 8.Who are the key players/companies in the global cancer cachexia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Cachexia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics

  • 6.1 Progestogens
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Corticosteroids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Mode of Action

  • 7.1 Appetite Stimulators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Weight Loss Stabilizers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Stores
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AAVogen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Actimed Therapeutics Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Aphios Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Artelo Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 AVEO Pharmaceuticals Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Helsinn Healthcare SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 NGM Biopharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tetra Bio-Pharma
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2024
  • Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2024
  • Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
  • Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
  • Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million USD), 2025-2033
  • Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million USD), 2025-2033
  • Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cancer Cachexia Market: Competitive Structure
  • Table 7: Global: Cancer Cachexia Market: Key Players